Fcγ receptors as regulators of immune responses
The DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Abstract
In addition to their role in binding antigen, antibodies can regulate immune responses through interacting with Fc receptors (FcRs). In recent years, significant progress has been made in understanding the mechanisms that regulate the activity of IgG antibodies in vivo. In this Review, we discuss recent studies addressing the multifaceted roles of FcRs for IgG (FcgammaRs) in the immune system and how this knowledge could be translated into novel therapeutic strategies to treat human autoimmune, infectious or malignant diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FcγR activation induces macrophage phagocytosis.44”
From Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling (2023) · cites this paper as [44]
Citations
Cites
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Self-citationShields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754 · cited 1×
“Evidence that this sugar residue is involved in immune regulatory processes was obtained by studying the mechanism of the anti-inflammatory activity of IVIG therap”
BackgroundSelf-citationDifferential Antigen Processing by Dendritic Cell Subsets in Vivo
Dudziak, D., Kamphorst, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H.-W., Park, C. G., et al. (2007) · Science · doi:10.1126/science.1136080 · Cited by 1,455
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210665200 · Cited by 1,413
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,307 · cited 1×
“This sugar side chain consists of a conserved biantennary heptasaccharide core structure containing mannose and N-acetylglucosamine (GlcNac) with varying additions of terminal and branching residues such as fucose, GlcNac, galactose and sialic aci”
BackgroundWeng, W.-K., & Levy, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.013 · Cited by 1,300 · cited 1×
“Several studies of lymphoma patients who had received Rituximab, a B-cell depleting chimeric IgG1 antibody that is specific for CD20, revealed that those patients with activating FcγR alleles that had a higher binding affinity for the Fc fragment of the therapeutic antibody displayed significantly improved clinical re…”
BackgroundRavetch, J. V., & Lanier, L. L. (2000) · Science · doi:10.1126/science.290.5489.84 · Cited by 1,283 · cited 1×
“The family of Fc receptors (FcRs) for IgG (FcγRs) provides a prime example of how simultaneous triggering of activating and inhibitory signalling pathways sets thresholds for cell activation and thus generates a well-balanced immune respons”
BackgroundSelf-citationInducing and expanding regulatory T cell populations by foreign antigen
Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M. C., & von Boehmer, H. (2005) · Nature Immunology · doi:10.1038/ni1265 · Cited by 1,241
Shields, R. L., Namenuk, A. K., Hong, K., Meng, Y. G., Rae, J., Briggs, J., Xie, D., Lai, J., Stadlen, A., Li, B., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009483200 · Cited by 1,161
Fcγ Receptors: Old Friends and New Family Members
Nimmerjahn, F., & Ravetch, J. V. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.010 · Cited by 1,072 · cited 1×
“In humans, monkeys and mice, most of the corresponding genes are clustered in close proximity on chromosome 1 next to the family of FcR homologous gene”
BackgroundSelf-citationAnti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,053
Self-citationDivergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,037 · cited 1×
“Similarly, despite the capacity of certain IgG subclasses to bind to several low-affinity receptors in vitro , it has become clear that this does not necessarily imply that all of these receptors are involved in mediating the effector functions of a specific IgG subclass in vivo”
BackgroundSelf-citationCompetence and competition: the challenge of becoming a long-lived plasma cell
Radbruch, A., Muehlinghaus, G., Luger, E. O., Inamine, A., Smith, K. G. C., Dörner, T., & Hiepe, F. (2006) · Nature Reviews Immunology · doi:10.1038/nri1886 · Cited by 1,030 · cited 1×
“Plasma cells reside predominantly in niches in the bone marrow, where they have to receive survival signals from stromal cell”
BackgroundMAST CELLS AS “TUNABLE” EFFECTOR AND IMMUNOREGULATORY CELLS: Recent Advances
Galli, S. J., Kalesnikoff, J., Grimbaldeston, M. A., Piliponsky, A. M., Williams, C. M. M., & Tsai, M. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141025 · Cited by 1,017 · cited 1×
“However, as has been described for the binding of IgE to the high-affinity FceRI, cell activation only ensues after the receptors have been crosslinked by antige”
BackgroundTHE HIGH-AFFINITY I g E RECEPTOR (FcεRI): From Physiology to Pathology
Kinet, J.-P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.931 · Cited by 968
FcR γ chain deletion results in pleiotrophic effector cell defects
Takai, T., Li, M., Sylvestre, D., Clynes, R., & Ravetch, J. V. (1994) · Cell · doi:10.1016/0092-8674(94)90115-5 · Cited by 951 · cited 1×
“A crucial step in elucidating the important role of activating FcγRs was the generation of γ-chain-deficient mic”
BackgroundSelf-citationRegnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Théry, C., Rescigno, M., Saito, T., Verbeek, S., Bonnerot, C., Ricciardi-Castagnoli, P., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.371 · Cited by 898
Augmented humoral and anaphylactic responses in FcγRII-deficient mice
Takai, T., Ono, M., Hikida, M., Ohmori, H., & Ravetch, J. V. (1996) · Nature · doi:10.1038/379346a0 · Cited by 826
Self-citationEngineered antibody Fc variants with enhanced effector function
Lazar, G. A., Dang, W., Karki, S., Vafa, O., Peng, J. S., Hyun, L., Chan, C., Chung, H. S., Eivazi, A., Yoder, S. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508123103 · Cited by 803 · cited 1×
“With the availability of antibody variants with enhanced binding to either activating or inhibitory FcγRs, however, it might become possible to integrate an additional activating or inhibitory second signal into the antibody–antigen fusion protei”
BackgroundMalhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B., Dwek, R. A., & Sim, R. B. (1995) · Nature Medicine · doi:10.1038/nm0395-237 · Cited by 786
Ono, M., Bolland, S., Tempst, P., & Ravetch, J. V. (1996) · Nature · doi:10.1038/383263a0 · Cited by 781
Self-citationSpontaneous Autoimmune Disease in FcγRIIB-Deficient Mice Results from Strain-Specific Epistasis
Bolland, S., & Ravetch, J. V. (2000) · Immunity · doi:10.1016/s1074-7613(00)00027-3 · Cited by 752
Self-citationThe 3.2-Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex
Sondermann, P., Huber, R., Oosthuizen, V., & Jacob, U. (2000) · Nature · doi:10.1038/35018508 · Cited by 719
Cellular and genetic mechanisms of self tolerance and autoimmunity
Goodnow, C. C., Sprent, J., de St Groth, B. F., & Vinuesa, C. G. (2005) · Nature · doi:10.1038/nature03724 · Cited by 699 · cited 1×
“Groundbreaking work over the last few years has established that several central and peripheral checkpoints exist throughout B-cell development to prevent the generation of autoreactive antibodie”
BackgroundArthritis Critically Dependent on Innate Immune System Players
Ji, H., Ohmura, K., Mahmood, U., Lee, D. M., Hofhuis, F. M. A., Boackle, S. A., Takahashi, K., Holers, V. M., Walport, M., Gerard, C., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00275-3 · Cited by 693 · cited 1×
“In model systems in which the IgG1 subclass is exclusively responsible for the phenotype, as for example in the K/BxN serum transfer arthritis model or in antibody-mediated tumour-cell, platelet or red-blood-cell depletion studies, animals deficient in FcγRIII showed abrogated antibody activit”
BackgroundThe Biology of IgE and the Basis of Allergic Disease
Gould, H. J., Sutton, B. J., Beavil, A. J., Beavil, R. L., McCloskey, N., Coker, H. A., Fear, D., & Smurthwaite, L. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141103 · Cited by 685 · cited 1×
“However, as has been described for the binding of IgE to the high-affinity FceRI, cell activation only ensues after the receptors have been crosslinked by antige”
BackgroundConvergent Solutions to Binding at a Protein-Protein Interface
DeLano, W. L., Ultsch, M. H., de, A. M., Vos, & Wells, J. A. (2000) · Science · doi:10.1126/science.287.5456.1279 · Cited by 672
Stuart, L. M., & Ezekowitz, R. A. B. (2005) · Immunity · doi:10.1016/j.immuni.2005.05.002 · Cited by 667
FcγRIV: A Novel FcR with Distinct IgG Subclass Specificity
Nimmerjahn, F., Bruhns, P., Horiuchi, K., & Ravetch, J. V. (2005) · Immunity · doi:10.1016/j.immuni.2005.05.010 · Cited by 660
Self-citationUchida, J., Hamaguchi, Y., Oliver, J. A., Ravetch, J. V., Poe, J. C., Haas, K. M., & Tedder, T. F. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040119 · Cited by 642
Self-citationRoles of Fc receptors in autoimmunity
Takai, T. (2002) · Nature Reviews Immunology · doi:10.1038/nri856 · Cited by 626
A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling
Muta, T., Kurosaki, T., Misulovin, Z., Sanchez, M., Nussenzweig, M. C., & Ravetch, J. V. (1994) · Nature · doi:10.1038/368070a0 · Cited by 580
Self-citationMolecular Basis of Fc Receptor Function
Hulett, M. D., & Hogarth, P. M. (1994) · Advances in Immunology · doi:10.1016/s0065-2776(08)60671-9 · Cited by 505 · cited 1×
“Traditionally, FcγR families are categorized according to the level of the receptor's affinity for specific IgG subclasses and the type of signalling pathway that it triggers — that is, whether it is inhibitory or activatin”
BackgroundDeletion of SHIP or SHP-1 Reveals Two Distinct Pathways for Inhibitory Signaling
Ono, M., Okada, H., Bolland, S., Yanagi, S., Kurosaki, T., & Ravetch, J. V. (1997) · Cell · doi:10.1016/s0092-8674(00)80337-2 · Cited by 499 · cited 1×
“Simultaneous triggering of ITIM-containing proteins with the BCR results in the recruitment of phosphatases such as SHIP (SH2-domain-containing inositol polyphosphate 5′ phosphatase) and SHP1 (SH2-domain-containing protein tyrosine phosphatase 1) that interfere with activating signalling pathways by hydrolysing phosph…”
BackgroundSelf-citationCytoplasmic Domain Heterogeneity and Functions of IgG Fc Receptors in B Lymphocytes
Amigorena, S., Bonnerot, C., Drake, J. R., Choquet, D., Hunziker, W., Guillet, J.-G., Webster, P., Sautes, C., Mellman, I., & Fridman, W. H. (1992) · Science · doi:10.1126/science.1535455 · Cited by 455 · cited 1×
“One common theme that emerged from these studies is the importance of the ITIMs found in the cytoplasmic domains of these protein”
BackgroundImpaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient Mice
Hazenbos, W. L. W., Gessner, J. E., Hofhuis, F. M. A., Kuipers, H., Meyer, D., Heijnen, I. A. F. M., Schmidt, R. E., Sandor, M., Capel, P. J. A., Daëron, M., et al. (1996) · Immunity · doi:10.1016/s1074-7613(00)80494-x · Cited by 443 · cited 1×
“In model systems in which the IgG1 subclass is exclusively responsible for the phenotype, as for example in the K/BxN serum transfer arthritis model or in antibody-mediated tumour-cell, platelet or red-blood-cell depletion studies, animals deficient in FcγRIII showed abrogated antibody activit”
BackgroundHoyer, B. F., Moser, K., Hauser, A. E., Peddinghaus, A., Voigt, C., Eilat, D., Radbruch, A., Hiepe, F., & Manz, R. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040168 · Cited by 440
Dendritic Cell Function in Vivo during the Steady State: A Role in Peripheral Tolerance
STEINMAN, R. M., HAWIGER, D., LIU, K., BONIFAZ, L., BONNYAY, D., MAHNKE, K., IYODA, T., RAVETCH, J., DHODAPKAR, M., INABA, K., et al. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb06029.x · Cited by 426
Self-citationOdendahl, M., Mei, H., Hoyer, B. F., Jacobi, A. M., Hansen, A., Muehlinghaus, G., Berek, C., Hiepe, F., Manz, R., Radbruch, A., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2507 · Cited by 424 · cited 1×
“How newly generated plasma cells gain access to these niches has remained a matter of debate, and models such as competitive dislocation have been proposed to explain this proble”
BackgroundCell Surface Recycling of Internalized Antigen Permits Dendritic Cell Priming of B Cells
Bergtold, A., Desai, D. D., Gavhane, A., & Clynes, R. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.013 · Cited by 401 · cited 1×
“The magnitude of this response is controlled by the inhibitory FcγRIIB, as DCs derived from Fcgriib -knockout mice generate stronger and longer-lasting immune responses in vitro and in vivo”
BackgroundCrystal Structure at 2.8 Å of an FcRn/Heterodimeric Fc Complex
Martin, W. L., West, A. P., Gan, L., & Bjorkman, P. J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00230-1 · Cited by 391
Clynes, R., Maizes, J. S., Guinamard, R., Ono, M., Takai, T., & Ravetch, J. V. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.1.179 · Cited by 387
Self-citationActivating and inhibitory IgG Fc receptors on human DCs mediate opposing functions
Boruchov, A. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24772 · Cited by 377 · cited 1×
“More importantly, FcγRIIB-deficient DCs or DCs incubated with a monoclonal antibody that blocks immune complex binding to FcγRIIB showed a spontaneous maturatio”
BackgroundKalergis, A. M., & Ravetch, J. V. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020338 · Cited by 372
Self-citationDIVERGENT ROLES FOR F c RECEPTORS AND COMPLEMENT IN VIVO
Ravetch, J. V., & Clynes, R. A. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.421 · Cited by 366
Self-citationMcKean, D. (2004) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)61579-7 · Cited by 364
The Structure of a Human Type III Fcγ Receptor in Complex with Fc
Radaev, S., Motyka, S., Fridman, W.-H., Sautes-Fridman, C., & Sun, P. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100350200 · Cited by 354
The Carbohydrate at FcγRIIIa Asn-162
Ferrara, C., Stuart, F., Sondermann, P., Brünker, P., & Umaña, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510171200 · Cited by 354 · cited 1×
“Branching sugar residues such as N-acetylglucosamine or fucose have been implicated in affecting antibody activity in vitro and in vivo”
BackgroundDhodapkar, K. M., Krasovsky, J., Williamson, B., & Dhodapkar, M. V. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011097 · Cited by 349
The coordination of signaling during Fc receptor-mediated phagocytosis
Swanson, J. A., & Hoppe, A. D. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0804439 · Cited by 331 · cited 1×
“Another important function of activating FcγRs is their capacity to endocytose or phagocytose immune complexes, which includes antibody-coated microorganisms and soluble protein”
BackgroundInfusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura
Debré, M., Griscelli, C., Bonnet, M.-C., Carosella, E., Philippe, N., Reinert, P., Vilmer, E., Kaplan, C., Fridman, W. H., & Teillaud, J.-L. (1993) · The Lancet · doi:10.1016/0140-6736(93)92000-j · Cited by 329
Deletion of Fcγ Receptor IIB Renders H-2b Mice Susceptible to Collagen-induced Arthritis
Yuasa, T., Kubo, S., Yoshino, T., Ujike, A., Matsumura, K., Ono, M., Ravetch, J. V., & Takai, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.1.187 · Cited by 325
Self-citationFc Receptors Initiate the Arthus Reaction: Redefining the Inflammatory Cascade
Sylvestre, D. L., & Ravetch, J. V. (1994) · Science · doi:10.1126/science.8066448 · Cited by 321
Self-citationLoss of function of a lupus-associated FcγRIIb polymorphism through exclusion from lipid rafts
Floto, R. A., Clatworthy, M. R., Heilbronn, K. R., Rosner, D. R., MacAry, P. A., Rankin, A., Lehner, P. J., Ouwehand, W. H., Allen, J. M., Watkins, N. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1288 · Cited by 316
Ioan-Facsinay, A., de Kimpe, S. J., Hellwig, S. M. M., van Lent, P. L., Hofhuis, F. M. A., van Ojik, H. H., Sedlik, C., da Silveira, S. A., Gerber, J., de Jong, Y. F., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00294-7 · Cited by 304
Bruhns, P., Samuelsson, A., Pollard, J. W., & Ravetch, J. V. (2003) · Immunity · doi:10.1016/s1074-7613(03)00080-3 · Cited by 304 · cited 1×
“Data from human clinical trials and a variety of mouse model systems clearly demonstrated that the Fc fragment contains most of the anti-inflammatory activit”
BackgroundSelf-citationFcγRIIb controls bone marrow plasma cell persistence and apoptosis
Xiang, Z., Cutler, A. J., Brownlie, R. J., Fairfax, K., Lawlor, K. E., Severinson, E., Walker, E. U., Manz, R. A., Tarlinton, D. M., & Smith, K. G. C. (2007) · Nature Immunology · doi:10.1038/ni1440 · Cited by 296
The antiinflammatory activity of IgG: the intravenous IgG paradox
Nimmerjahn, F., & Ravetch, J. V. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061788 · Cited by 280
Self-citationStructural Comparison of Fucosylated and Nonfucosylated Fc Fragments of Human Immunoglobulin G1
Matsumiya, S., Yamaguchi, Y., Saito, J.-I., Nagano, M., Sasakawa, H., Otaki, S., Satoh, M., Shitara, K., & Kato, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.02.034 · Cited by 278
Resistance of Fc receptor- deficient mice to fatal glomerulonephritis.
Park, S. Y., Ueda, S., Ohno, H., Hamano, Y., Tanaka, M., Shiratori, T., Yamazaki, T., Arase, H., Arase, N., Karasawa, A., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3256 · Cited by 263
Restoration of Tolerance in Lupus by Targeted Inhibitory Receptor Expression
McGaha, T. L., Sorrentino, B., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1105160 · Cited by 261 · cited 1×
“Indeed, this approach successfully prevented the development of autoimmune disease in several mouse strains prone to autoimmunit”
BackgroundSelf-citationIsolation and Expression of Functional High-Affinity Fc Receptor Complementary DNAs
Allen, J. M., & Seed, B. (1989) · Science · doi:10.1126/science.2911749 · Cited by 258 · cited 1×
“By contrast, the high-affinity receptor FcγRI contains an additional immunoglobulin-like domain (D3), which has been suggested to be important for high-affinity bindin”
BackgroundGenetic Modifiers of Systemic Lupus Erythematosus in FcγRIIB−/− Mice
Bolland, S., Yim, Y.-S., Tus, K., Wakeland, E. K., & Ravetch, J. V. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020165 · Cited by 256
Self-citationAgalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity
Nimmerjahn, F., Anthony, R. M., & Ravetch, J. V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702936104 · Cited by 253 · cited 1×
“More recent data, however, argues against the involvement of the lectin pathway of complement activatio”
BackgroundSelf-citationSelective dysregulation of the FcγIIB receptor on memory B cells in SLE
Mackay, M., Stanevsky, A., Wang, T., Aranow, C., Li, M., Koenig, S., Ravetch, J. V., & Diamond, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051503 · Cited by 252
Self-citationCytotoxic antibodies trigger inflammation through Fc receptors
Clynes, R., & Ravetch, J. V. (1995) · Immunity · doi:10.1016/1074-7613(95)90155-8 · Cited by 250
Self-citationIntravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells
Siragam, V., Crow, A. R., Brinc, D., Song, S., Freedman, J., & Lazarus, A. H. (2006) · Nature Medicine · doi:10.1038/nm1416 · Cited by 246
Kaneko, Y., Nimmerjahn, F., Madaio, M. P., & Ravetch, J. V. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051900 · Cited by 246
Self-citationFukuyama, H., Nimmerjahn, F., & Ravetch, J. V. (2005) · Nature Immunology · doi:10.1038/ni1151 · Cited by 244
Self-citationContrasting IgG Structures Reveal Extreme Asymmetry and Flexibility
Saphire, E. O., Stanfield, R. L., Max Crispin, M. D., Parren, P. W. H. I., Rudd, P. M., Dwek, R. A., Burton, D. R., & Wilson, I. A. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00244-9 · Cited by 243
Dhodapkar, K. M., Kaufman, J. L., Ehlers, M., Banerjee, D. K., Bonvini, E., Koenig, S., Steinman, R. M., Ravetch, J. V., & Dhodapkar, M. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500014102 · Cited by 241
Self-citationHamaguchi, Y., Xiu, Y., Komura, K., Nimmerjahn, F., & Tedder, T. F. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052283 · Cited by 237 · cited 1×
“Similarly, despite the capacity of certain IgG subclasses to bind to several low-affinity receptors in vitro , it has become clear that this does not necessarily imply that all of these receptors are involved in mediating the effector functions of a specific IgG subclass in vivo”
BackgroundSelf-citationAntibodies, Fc receptors and cancer
Nimmerjahn, F., & Ravetch, J. V. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.01.005 · Cited by 234 · cited 1×
“In situations in which a maximal immune response is desirable, such as immunotherapy of malignancies or microbial infections, blocking FcγRIIB activity might be a novel way to obtain greater therapeutic efficac”
BackgroundSelf-citationImmune complex–mediated antigen presentation induces tumor immunity
Rafiq, K., Bergtold, A., & Clynes, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215640 · Cited by 232
Kono, H., Kyogoku, C., Suzuki, T., Tsuchiya, N., Honda, H., Yamamoto, K., Tokunaga, K., & Honda, Z.-I. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi320 · Cited by 226
Corper, A. L., Sohi, M. K., Bonagura, V. R., Steinitz, M., Jefferis, R., Feinstein, A., Beale, D., Taussig, M. J., & Sutton, B. J. (1997) · Nature Structural & Molecular Biology · doi:10.1038/nsb0597-374 · Cited by 224
Hawiger, D., Masilamani, R. F., Bettelli, E., Kuchroo, V. K., & Nussenzweig, M. C. (2004) · Immunity · doi:10.1016/j.immuni.2004.05.002 · Cited by 224
Inhibitory Pathways Triggered by ITIM-Containing Receptors
Bolland, S., & Ravetch, J. V. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60019-x · Cited by 220
Self-citationSHIP Recruitment Attenuates FcγRIIB-Induced B Cell Apoptosis
Pearse, R. N., Kawabe, T., Bolland, S., Guinamard, R., Kurosaki, T., & Ravetch, J. V. (1999) · Immunity · doi:10.1016/s1074-7613(00)80074-6 · Cited by 219 · cited 1×
“Similarly, the homo-oligomerization of FcγRIIB resulted in increased levels of B-cell death, and it was shown later that a signalling pathway dependent on BTK, JNK1 and cABL, but independent of SHIP and ITIM, was responsible for this phenotyp”
BackgroundSelf-citationThe three-dimensional structure of an intact monoclonal antibody for canine lymphoma
Harris, L. J., Larson, S. B., Hasel, K. W., Day, J., Greenwood, A., & McPherson, A. (1992) · Nature · doi:10.1038/360369a0 · Cited by 217
Woelbing, F., Kostka, S. L., Moelle, K., Belkaid, Y., Sunderkoetter, C., Verbeek, S., Waisman, A., Nigg, A. P., Knop, J., Udey, M. C., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052288 · Cited by 211
Pritchard, N. R., Cutler, A. J., Uribe, S., Chadban, S. J., Morley, B. J., & Smith, K. G. C. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00344-4 · Cited by 210
Nakamura, A., Yuasa, T., Ujike, A., Ono, M., Nukiwa, T., Ravetch, J. V., & Takai, T. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.899 · Cited by 208
Self-citationFcγRI-Deficient Mice Show Multiple Alterations to Inflammatory and Immune Responses
Barnes, N., Gavin, A. L., Tan, P. S., Mottram, P., Koentgen, F., & Hogarth, P. M. (2002) · Immunity · doi:10.1016/s1074-7613(02)00287-x · Cited by 207
RECEPTORS FOR AGGREGATED IgG ON MOUSE LYMPHOCYTES
Anderson, C. L., & Grey, H. M. (1974) · The Journal of Experimental Medicine · doi:10.1084/jem.139.5.1175 · Cited by 206
Ghazizadeh, S., Bolen, J. B., & Fleit, H. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37050-3 · Cited by 202
Immunoglobulin G–mediated Inflammatory Responses Develop Normally in Complement-deficient Mice
Sylvestre, D., Clynes, R., Ma, M., Warren, H., Carroll, M. C., & Ravetch, J. V. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2385 · Cited by 202
Self-citationHOLMES, M. C., & BURNET, F. M. (1963) · Annals of Internal Medicine · doi:10.7326/0003-4819-59-3-265 · Cited by 198
Kiener, P. A., Rankin, B. M., Burkhardt, A. L., Schieven, G. L., Gilliland, L. K., Rowley, R. B., Bolen, J. B., & Ledbetter, J. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80545-6 · Cited by 196
Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa.
Hogarth, P. M., Maxwell, K. F., Powell, M. S., Hulett, M. D., Bartoň, P., McKenzie, I. F. C., & Garrett, T. (1999) · Nature Structural Biology · doi:10.1038/8241 · Cited by 195
Weng, W.-K., Czerwinski, D., Timmerman, J., Hsu, F. J., & Levy, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.003 · Cited by 191 · cited 1×
“Several studies of lymphoma patients who had received Rituximab, a B-cell depleting chimeric IgG1 antibody that is specific for CD20, revealed that those patients with activating FcγR alleles that had a higher binding affinity for the Fc fragment of the therapeutic antibody displayed significantly improved clinical re…”
BackgroundFossati-Jimack, L., Ioan-Facsinay, A., Reininger, L., Chicheportiche, Y., Watanabe, N., Saito, T., Hofhuis, F. M. A., Gessner, J. E., Schiller, C., Schmidt, R. E., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1293 · Cited by 180
Su, K., Wu, J., Edberg, J. C., Li, X., Ferguson, P., Cooper, G. S., Langefeld, C. D., & Kimberly, R. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7186 · Cited by 179
Inflammation in autoimmunity: receptors for IgG revisited
Dijstelbloem, H. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02014-2 · Cited by 176 · cited 1×
“The complexity in the FcγR family is mirrored by the presence of four different IgG subclasses in humans (IgG1–IgG4) and mice (IgG1, IgG2a, IgG2b and IgG3), which bind with varying affinity and specificity to different FcγR receptor”
BackgroundFc receptors and their interaction with complement in autoimmunity
Schmidt, R. E., & Gessner, J. E. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.06.022 · Cited by 174 · cited 1×
“By contrast, late components of the complement cascade, such as C5a, have been shown to be required in a model of autoimmune haemolytic anaemia (AIHA”
BackgroundCrystal Structure of the Human High-Affinity IgE Receptor
Garman, S. C., Kinet, J.-P., & Jardetzky, T. S. (1998) · Cell · doi:10.1016/s0092-8674(00)81719-5 · Cited by 171
Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility
Jiang, Y., Hirose, S., Abe, M., Sanokawa-Akakura, R., Ohtsuji, M., Mi, X., Li, N., Xiu, Y., Zhang, D., Shirai, J., et al. (2000) · Immunogenetics · doi:10.1007/s002510050641 · Cited by 166
Mannan binding lectin and its interaction with immunoglobulins in health and in disease
Arnold, J. N., Dwek, R. A., Rudd, P. M., & Sim, R. B. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.05.007 · Cited by 165 · cited 1×
“In addition, autoimmune-prone mouse strains such as MRL also have an increase in this specific IgG glycovariant, suggesting that the absence of these terminal sugar residues might be involved in autoantibody pathogenicit”
BackgroundBlank, M. C., Stefanescu, R. N., Masuda, E., Martí, F., King, P. D., Redecha, P. B., Wurzburger, R. J., Peterson, M. G. E., Tanaka, S., & Pricop, L. (2005) · Human Genetics · doi:10.1007/s00439-005-1302-3 · Cited by 164
Park-Min, K.-H., Serbina, N. V., Yang, W., Ma, X., Krystal, G., Neel, B. G., Nutt, S. L., Hu, X., & Ivashkiv, L. B. (2007) · Immunity · doi:10.1016/j.immuni.2006.11.010 · Cited by 158 · cited 1×
“In other models systems a role for the activating FcγRIII in mediating IVIG-like effects was propose”
BackgroundRegulation of Phagocytosis and [Ca 2+ ] i Flux by Distinct Regions of an Fc Receptor
Odin, J. A., Edberg, J. C., Painter, C. J., Kimberly, R. P., & Unkeless, J. C. (1991) · Science · doi:10.1126/science.1837175 · Cited by 149
Stout, R. D., & Herzenberg, L. A. (1975) · The Journal of Experimental Medicine · doi:10.1084/jem.142.3.611 · Cited by 149
da Silveira, S. A., Kikuchi, S., Fossati‐Jimack, L., Moll, T., Saito, T., Verbeek, J. S., Botto, M., Walport, M. J., Carroll, M. C., & Izui, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012024 · Cited by 149
Molecular Basis for Immune Complex Recognition: A Comparison of Fc-Receptor Structures
Sondermann, P., Kaiser, J. T., & Jacob, U. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4670 · Cited by 147
Liao, F., Shin, H. S., & Rhee, S. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3659 · Cited by 144
Wang, A. V., Scholl, P. R., & Geha, R. S. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.3.1165 · Cited by 144
Recognition of immunoglobulins by Fcγ receptors
Radaev, S., & Sun, P. D. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00036-6 · Cited by 136
Meyer, D., Schiller, C., Westermann, J., Izui, S., Hazenbos, W. L. W., Verbeek, J. S., Schmidt, R. E., & Gessner, J. E. (1998) · Blood · doi:10.1182/blood.v92.11.3997 · Cited by 124
Sondermann, P., Huber, R., & Jacob, U. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1095 · Cited by 123
FcR-Bearing Myeloid Cells Are Responsible for Triggering Murine Lupus Nephritis
Bergtold, A., Gavhane, A., D’Agati, V. D., Madaio, M. P., & Clynes, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7287 · Cited by 122 · cited 1×
“Indeed, myeloid cells that abundantly express FcγRIIB have been suggested to be the responsible effector-cell type in models of ADCC and SL”
BackgroundIns and Outs of Dendritic Cells
Schuurhuis, D. H., Fu, N., OSSENDORP, F. A., & Melief, C. J. M. (2006) · International Archives of Allergy and Immunology · doi:10.1159/000092002 · Cited by 121 · cited 1×
“A great number of activating and inhibitory cell-surface proteins involved in the regulation of DC activation have been identifie”
BackgroundImmune Complex-Loaded Dendritic Cells Are Superior to Soluble Immune Complexes as Antitumor Vaccine
Schuurhuis, D. H., van Montfoort, N., Ioan‐Facsinay, A., Jiawan-Lalai, R., Camps, M. G. M., Nouta, J., Melief, C. J. M., Verbeek, J. S., & OSSENDORP, F. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4573 · Cited by 119
Xiu, Y., Nakamura, K., Abe, M., Li, N., Wen, X., Jiang, Y., Zhang, D., Tsurui, H., Matsuoka, S., Hamano, Y., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4340 · Cited by 118
Crystal Structure of the Extracellular Domain of a Human FcγRIII
Zhang, Y., Boesen, C. C., Radaev, S., Brööks, A. G., Fridman, W. H., Sautès‐Fridman, C., & Sun, P. D. (2000) · Immunity · doi:10.1016/s1074-7613(00)00038-8 · Cited by 118 · cited 1×
“Consistent with previous studies, the crystal structure suggests a 1:1 stoichiometry for the IgG1–FcγR interactio”
ResultCell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice
Kumar, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25536 · Cited by 118
Jiang, Y., Hirose, S., Sanokawa‐Akakura, R., Abe, M., Mi, X., Li, N., Miura, Y., Shirai, J., Zhang, D., Hamano, Y., et al. (1999) · International Immunology · doi:10.1093/intimm/11.10.1685 · Cited by 112
Su, K., Li, X., Edberg, J. C., Wu, J., Ferguson, P. J., & Kimberly, R. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7192 · Cited by 107
Molecular interactions regulate BCR signal inhibition by CD22 and CD72
Nitschke, L., & Tsubata, T. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.08.002 · Cited by 102
Fc receptor blockade and immune thrombocytopenic purpura
Bussel, J. B. (2000) · Seminars in Hematology · doi:10.1016/s0037-1963(00)90104-5 · Cited by 101 · cited 1×
“In addition, blocking FcγRIIIA in human patients with ITP significantly inhibited platelet depletion by human platelet-specific antibodie”
BackgroundMuta, T., Kurosaki, T., Misulovin, Z., Sanchez, M., Nussenzweig, M. C., & Ravetch, J. V. (1994) · Nature · doi:10.1038/369340a0 · Cited by 101
Self-citationTzeng, S., Bolland, S. M., Inabe, K., Kurosaki, T., & Pierce, S. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505308200 · Cited by 92
Groh, V., Li, Y. Q., Cioca, D., Hunder, N. N. H., Wang, W., Riddell, S. R., Yee, C., & Spies, T. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501953102 · Cited by 91
Rankin, B. M., Yocum, S. A., Mittler, R. S., & Kiener, P. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.2.605 · Cited by 88
Activating and inhibitory FcγRs in autoimmune disorders
Nimmerjahn, F. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0052-1 · Cited by 76
Self-citationStructural changes in the oligosaccharide chains of IgG in autoimmune MRL/Mp- lpr/lpr mice.
Mizuochi, T., Hamako, J., Nose, M., & Titani, K. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.6.1794 · Cited by 73
Bond, A., Cooke, A., & Hay, F. C. (1990) · European Journal of Immunology · doi:10.1002/eji.1830201011 · Cited by 69
Zhang, M., Zhang, Z., Garmestani, K., Goldman, C. K., Ravetch, J. V., Brechbiel, M. W., Carrasquillo, J. A., & Waldmann, T. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1088 · Cited by 66
Self-citationReconstitution of human Fc gamma RIII cell type specificity in transgenic mice.
Li, M. Y., Wirthmueller, U., & Ravetch, J. V. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.3.1259 · Cited by 65
Self-citationConsidering Therapeutic Antibodies
Vitetta, E. S., & Ghetie, V. F. (2006) · Science · doi:10.1126/science.1130482 · Cited by 36 · cited 1×
“Animal models, be they rodent or non-human primate models, are inadequate, as exemplified by the catastrophic outcome of a recent clinical trial with a CD28-specific superagonistic antibod”
BackgroundFollicular exclusion of autoreactive B cells requires Fc RIIb
Paul, E., Nelde, A., Verschoor, A., & Carroll, M. C. (2007) · International Immunology · doi:10.1093/intimm/dxm002 · Cited by 31
A conformational change in the Fc precludes the binding of two Fcγ receptor molecules to one IgG
Kato, K., Fridman, W. H., Arata, Y., & Sautès‐Fridman, C. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01666-2 · Cited by 27
Killing some to make way for others
Ravetch, J. V., & Nussenzweig, M. C. (2007) · Nature Immunology · doi:10.1038/ni0407-337 · Cited by 25 · cited 1×
“The pro-apoptotic signals triggered by isolated FcγRIIB crosslinking by immune complexes on plasma cells might be another elegant solution to this proble”
BackgroundSelf-citationLeclerc, J. C., Plater, C., & Fridman, W. H. (1977) · European Journal of Immunology · doi:10.1002/eji.1830070810 · Cited by 22
Direct targeting of genetically modified tumour cells to FcγRI triggers potent tumour cytotoxicity
Bevaart, L., Goldstein, J., Vitale, L. A., Russoniello, C., Treml, J., Zhang, J., Graziano, R. F., Leusen, J. H. W., van de Winkel, J. G. J., & Keler, T. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05884.x · Cited by 14
Cited by
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
“Such complexes may also activate the complement system and lead to further unwanted inflammation 141 .”
BackgroundA single-cell atlas of the peripheral immune response in patients with severe COVID-19
Wilk, A. J., Rustagi, A., Zhao, N. Q., Roque, J., Martínez-Colón, G. J., McKechnie, J. L., Ivison, G. T., Ranganath, T., Vergara, R., Hollis, T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0944-y · Cited by 1,493
Simpson, T. R., Li, F., Montalvo-Ortiz, W., Sepulveda, M. A., Bergerhoff, K., Arce, F., Roddie, C., Henry, J. Y., Yagita, H., Wolchok, J. D., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130579 · Cited by 1,472
“In mice, ADCC is regulated predominantly by the low-affinity receptors FcRIII and FcRIV (Nimmerjahn et al., 2005; Nimmerjahn et al., 2010; Setiady et al., 2010), and to a lesser extent by the highaffinity FcRI (Fossati-Jimack et al., 2000; Tedder et al., 2006; Hamaguchi et al., 2006).”
BackgroundInfluentialSelf-citationControlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
Long, E. O., Sik Kim, H., Liu, D., Peterson, M. E., & Rajagopalan, S. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075005 · Cited by 1,217
“The concept and existence of the ITIM was first established with FcγRIIb, which inhibits B cell receptor signaling by recruiting the inositol phosphatase SHIP when coligated through binding of IgG immune complexes (150, 152).”
BackgroundWiner, D. A., Winer, S., Shen, L., Wadia, P. P., Yantha, J., Paltser, G., Tsui, H., Wu, P., Davidson, M. G., Alonso, M. N., et al. (2011) · Nature Medicine · doi:10.1038/nm.2353 · Cited by 1,050
Metadata
- Authors
- Nimmerjahn, F., & Ravetch, J. V.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Rockefeller University (US)
- Venue
- Nature Reviews Immunology
- Published
- 2008-01
- Volume
- 8
- Issue
- 1
- Pages
- 34-47
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2075901113
- Cited by
- 2,947
- References
- 139
- Citations by year
- 2026: 186 · 2025: 176 · 2024: 158 · 2023: 174 · 2022: 169 · 2021: 196 · 2020: 158 · 2019: 188 · 2018: 151 · 2017: 161 · 2016: 158 · 2015: 170 · 2014: 165 · 2013: 162 · 2012: 181
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- Fc gamma receptor, IgG, antibody subclasses, immune regulation, therapeutic antibodies, autoimmune disease, infectious diseases, cancer immunotherapy, antibody effector functions
- MeSH terms
- Animals, Humans, Immunoglobulin G, Immunity, Receptors, Fc
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.